162 related articles for article (PubMed ID: 38441911)
1. Reply: Is right heart assessment vital for evaluating terlipressin-related outcomes in hepatorenal syndrome-acute kidney injury?
Roy A; Kajal K; Izzy M; Sihag BK; Premkumar M
Hepatology; 2024 Jun; 79(6):E163-E164. PubMed ID: 38441911
[No Abstract] [Full Text] [Related]
2. Letter to the Editor: Is right heart assessment vital for evaluating terlipressin-related outcomes in hepatorenal syndrome-acute kidney injury?
Guo Q; Wang J; Wang G; Wang X
Hepatology; 2024 Jun; 79(6):E161-E162. PubMed ID: 38456783
[No Abstract] [Full Text] [Related]
3. Use of Terlipressin in AKI Associated with Hepatorenal Syndrome: PRO.
Belcher JM
Kidney360; 2024 Jun; 5(6):791-794. PubMed ID: 38526157
[No Abstract] [Full Text] [Related]
4. Use of Terlipressin in AKI Associated with Hepatorenal Syndrome: CON.
Willows J; Hiremath S
Kidney360; 2024 Jun; 5(6):795-798. PubMed ID: 38526155
[No Abstract] [Full Text] [Related]
5. Use of Terlipressin in AKI Associated with Hepatorenal Syndrome: COMMENTARY.
Allegretti AS
Kidney360; 2024 Jun; 5(6):799-801. PubMed ID: 38526154
[No Abstract] [Full Text] [Related]
6. Terlipressin. Type I hepatorenal syndrome: an extra window of time before liver transplantation.
Prescrire Int; 2006 Dec; 15(86):220. PubMed ID: 17171813
[TBL] [Abstract][Full Text] [Related]
7. Terlipressin in the treatment of hepatorenal syndrome: A systematic review and meta-analysis.
Wang H; Liu A; Bo W; Feng X; Hu Y
Medicine (Baltimore); 2018 Apr; 97(16):e0431. PubMed ID: 29668606
[TBL] [Abstract][Full Text] [Related]
8. Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome.
Kim HR; Lee YS; Yim HJ; Lee HJ; Ryu JY; Lee HJ; Yoon EL; Lee SJ; Hyun JJ; Jung SW; Koo JS; Choung RS; Lee SW; Choi JH
Clin Mol Hepatol; 2013 Dec; 19(4):417-20. PubMed ID: 24459647
[TBL] [Abstract][Full Text] [Related]
9. Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome.
Neri S; Pulvirenti D; Malaguarnera M; Cosimo BM; Bertino G; Ignaccolo L; Siringo S; Castellino P
Dig Dis Sci; 2008 Mar; 53(3):830-5. PubMed ID: 17939047
[TBL] [Abstract][Full Text] [Related]
10. Terlipressin for hepatorenal syndrome.
Wong F
Curr Opin Gastroenterol; 2024 May; 40(3):156-163. PubMed ID: 38353275
[TBL] [Abstract][Full Text] [Related]
11. Terlipressin in hepatorenal syndrome.
Mazur JE; Cooper TB; Dasta JF
Ann Pharmacother; 2011 Mar; 45(3):380-7. PubMed ID: 21386023
[TBL] [Abstract][Full Text] [Related]
12. Noradrenaline or terlipressin for hepatorenal syndrome?
Celis P; Rada G
Medwave; 2015 Aug; 15 Suppl 2():e6235. PubMed ID: 26334297
[TBL] [Abstract][Full Text] [Related]
13. Terlipressin versus other vasoactive drugs for hepatorenal syndrome.
Israelsen M; Krag A; Allegretti AS; Jovani M; Goldin AH; Winter RW; Gluud LL
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011532. PubMed ID: 28953318
[TBL] [Abstract][Full Text] [Related]
14. Terlipressin in hepatorenal syndrome: Evidence for present indications.
Rajekar H; Chawla Y
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():109-14. PubMed ID: 21199521
[TBL] [Abstract][Full Text] [Related]
15. Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome.
Allegretti AS; Israelsen M; Krag A; Jovani M; Goldin AH; Schulman AR; Winter RW; Gluud LL
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD005162. PubMed ID: 29943803
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis: terlipressin therapy for the hepatorenal syndrome.
Fabrizi F; Dixit V; Martin P
Aliment Pharmacol Ther; 2006 Sep; 24(6):935-44. PubMed ID: 16948805
[TBL] [Abstract][Full Text] [Related]
17. [A case of peripheral ischemic complication after terlipressin therapy].
Lee JS; Lee HS; Jung SW; Han WS; Kim MJ; Lee SW; Choi JH; Kim CD; Ryu HS; Hyun JH
Korean J Gastroenterol; 2006 Jun; 47(6):454-7. PubMed ID: 16809953
[TBL] [Abstract][Full Text] [Related]
18. Terlipressin for hepatorenal syndrome: opportunities and challenges.
Singal AK; Jalan R
Lancet Gastroenterol Hepatol; 2023 Feb; 8(2):104-106. PubMed ID: 36620975
[No Abstract] [Full Text] [Related]
19. Efficacy of treatment with terlipressin plus albumin in hepatorenal syndrome diagnosed with the new acute kidney injury versus the conventional criteria.
Kalambokis GN; Christaki M; Tsiakas I; Despotis G; Milionis HJ
Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1292-1294. PubMed ID: 31498285
[No Abstract] [Full Text] [Related]
20. Terlipressin for hepatorenal syndrome: continuous infusion as an alternative to i.v. bolus administration.
Gerbes AL; Huber E; Gülberg V
Gastroenterology; 2009 Sep; 137(3):1179; author reply 1179-81. PubMed ID: 19631603
[No Abstract] [Full Text] [Related]
[Next] [New Search]
